PIERIS PHARMACEUTICALS, INC. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Pieris Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Pieris Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Pieris Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $1.2M, a 45.5% decline year-over-year.
  • Pieris Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $2.2M, a 8.33% decline from 2022.
  • Pieris Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $2.4M, a 7.69% decline from 2021.
  • Pieris Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $2.6M, a 18.2% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.2M -$200K -8.33% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $2.4M -$200K -7.69% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $2.6M +$400K +18.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $2.2M +$1.7M +340% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $500K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.